Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Bausch + Lomb Corporation, Merit Medical Systems or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Bausch + Lomb Corporation, Merit Medical Systems and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Bausch + Lomb Corporation, Merit Medical Systems and Inc.

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Latest Health Care Equipment & Supplies and Bausch + Lomb Corporation, Merit Medical Systems, Inc. Stock News

As of September 2, 2026, Bausch + Lomb Corporation had a $6.4 billion market capitalization, compared to the Health Care Equipment & Supplies median of $416.1 million. Bausch + Lomb Corporation’s stock is up 5.4% in 2026, up 4.3% in the previous five trading days and up 21.54% in the past year.

Currently, Bausch + Lomb Corporation does not have a price-earnings ratio. Bausch + Lomb Corporation’s trailing 12-month revenue is $5.3 billion with a -3.2% net profit margin. Year-over-year quarterly sales growth most recently was 9.1%. Analysts expect adjusted earnings to reach $0.804 per share for the current fiscal year. Bausch + Lomb Corporation does not currently pay a dividend.

As of September 2, 2026, Merit Medical Systems, Inc. had a $5.4 billion market cap, putting it in the 68th percentile of all stocks. Merit Medical Systems, Inc.’s stock is up 2.3% in 2026, down 0.5% in the previous five trading days and down 0.61% in the past year.

Currently, Merit Medical Systems, Inc.’s price-earnings ratio is 37.1. Merit Medical Systems, Inc.’s trailing 12-month revenue is $1.6 billion with a 9.2% net profit margin. Year-over-year quarterly sales growth most recently was 9.5%. Analysts expect adjusted earnings to reach $4.302 per share for the current fiscal year. Merit Medical Systems, Inc. does not currently pay a dividend.

How We Compare Bausch + Lomb Corporation, Merit Medical Systems and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Bausch + Lomb Corporation, Merit Medical Systems and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Bausch + Lomb Corporation, Merit Medical Systems and Inc. Growth Grades

Company	Ticker	Growth
Bausch + Lomb Corporation	BLCO	B
Merit Medical Systems, Inc.	MMSI	A

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Bausch + Lomb Corporation has a Growth Score of 73, which is Strong. Merit Medical Systems, Inc. has a Growth Score of 100, which is Very Strong.

The Growth Grade Winner: Merit Medical Systems, Inc.

As you can clearly see from the Growth Grade breakdown above, Merit Medical Systems, Inc. has a more attractive growth grade than Bausch + Lomb Corporation. For investors who focus solely on how a company is growing relative to other companies in the same industry, Merit Medical Systems, Inc. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Bausch + Lomb Corporation, Merit Medical Systems and Inc.’s Momentum Grades

Company	Ticker	Momentum
Bausch + Lomb Corporation	BLCO	B
Merit Medical Systems, Inc.	MMSI	B

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Bausch + Lomb Corporation has a Momentum Score of 69, which is Strong. Merit Medical Systems, Inc. has a Momentum Score of 75, which is Strong.

The Momentum Grade Winner: It’s a Tie!

Looking at the Momentum Grade breakdown above, both Bausch + Lomb Corporation, Merit Medical Systems and Inc. have a grade of B. For those who focus solely on a company’s momentum, further research will need to be conducted into both companies to see if they fit your individual needs as an investor.

Bausch + Lomb Corporation, Merit Medical Systems and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Bausch + Lomb Corporation	BLCO	D
Merit Medical Systems, Inc.	MMSI	B

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Bausch + Lomb Corporation has a Earnings Estimate Score of 38, which is Negative. Merit Medical Systems, Inc. has a Earnings Estimate Score of 75, which is Positive.

The Earnings Estimate Revisions Grade Winner: Merit Medical Systems, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Merit Medical Systems, Inc. has a better Earnings Estimate Revisions Grade than Bausch + Lomb Corporation. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Merit Medical Systems, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Bausch + Lomb Corporation, Merit Medical Systems and Inc. Grades

In addition to Momentum, Growth and Estimate Revisions, A+ Investor also provides grades for Value and Quality.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Bausch + Lomb Corporation, Merit Medical Systems and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Bausch + Lomb Corporation, Merit Medical Systems or Inc. Stock?

Overall, Bausch + Lomb Corporation stock has a Growth Score of 73, Momentum Score of 69 and Estimate Revisions Score of 38.

Merit Medical Systems, Inc. stock has a Growth Score of 100, Momentum Score of 75 and Estimate Revisions Score of 75.

Comparing Bausch + Lomb Corporation, Merit Medical Systems and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.